Parathyroid hormone-related peptide and cardiovascular system

In Vivo

Volumn 17, Issue 5, 2003, Pages 425-432

  Halapas, Antonis ^a   Tenta, Roxane ^a   Pantos, Constantine ^a   Cokkinos, Dennis V ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cardiomyocytes; Parathyroid hormone related peptide; Vascular smooth muscle cells

Indexed keywords

ANDROGEN; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; CALCITONIN; CYTOKINE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GLUCOCORTICOID RECEPTOR; GROWTH FACTOR; HORMONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NORADRENALIN; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PROLACTIN; SEROTONIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D RECEPTOR;

AUTOCRINE EFFECT; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HORMONE ACTION; HUMAN; HYPERCALCEMIA; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0142229903     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H and Chen EY: A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 237: 893-896, 1987.
2. Martin TJ, Lam MHC, Katsogiannis V and Gillespie MT: Parathyroid Hormone-Related Protein. Skeletal Growth Factors, edited by Ernesto Canalis, Lippincott Williams & Wilkins Company, 2000.
3. Ikeda K, Weir EC, Mangin M, Dannies PS, Kinder B, Deftos LJ, Brown EM and Broadus AE: Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol 2: 1230-1236, 1988.
4. Weir EC, Brines ML, Ikeda K, Burtis WJ, Broadus AE and Robbins RJ: Parathyroid hormone-related peptide gene is expressed in the mammalian central nervous system. Proc Natl Acad Sci USA 87: 108-112, 1990.
5. Orloff JJ, Reddy D, De Papp AE, Yang KH, Soifer NE and Stewart AF: Parathyroid hormone-related protein as a prohormone: Posttranslational processing and receptor interactions. Endocr Rev 15: 40-60, 1994.
6. Mundy GR and Guise TA: Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and osteolytic bone disease. Endocr-Relat Cancer 5: 15-26, 1998.
7. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM and Mulligan RC: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide genes. Genes Dev 1; 8: 277-289, 1994.
8. Kronenberg HM, Lanske B, Kovacs CS, Chung UI, Lee K, Segre GV, Schipani E and Juppner H: Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res 53: 283-301, 1998.
9. Burtis WJ: Parathyroid hormone-related protein: Structure, function, and measurement. Clin Chem 38: 2171-2183, 1992.
10. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, Fischer E, Friedman PA, Karaplis AC, Massfelder T, Rossert J, Schluter KD, Silve C, Stewart AF, Takane K and Helwig JJ: Parathyroid hormone-related protein and its receptors: Nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Physiol 134: 1113-1136, 2001.
11. Mannstadt M, Jüppner H and Gardella TJ: Receptors for PTH and PTHrP: Their biological importance and functional properties. Am J Physiol-Renal 277: F665-F675, 1999.
12. Sclüter KD: PTH and PTHrP: Similar structures but different functions. News Physiol Sci 14: 243-248, 1999.
13. Bryden AAG, Islam S, Freemont AJ, Shanks JH, George NJR and Clarke NW: Parathyroid hormone-related peptide: Expression in prostate cancer bone metastases. Prostate Cancer P D 5: 59-62, 2002.
14. Goomer RS, Johnson KA, Burton DW, Anniel D, Maris TM, Curjal A, Deftos LS and Terkelaub R: The tetrabasic KKKK (147-150) motif determines intracrine regulation effect of PTHrP (1-113) on chondrocyte PPi metabolism and matrix synthesis. Endocrinology 141: 4613-4622, 2000.
15. Usdin TB, Gruber C and Bonner TI: Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270: 15455-15458, 1995.
16. Rubin DA and Jüppner H: Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTHIR) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem 274: 28185-28190, 1999.
17. Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M and Lohse MJ: Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and β-arrestins. Endocrinology 143: 3854-3865, 2002.
18. Gardella TJ and Jüppner H: Molecular properties of the PTH/PTHrP receptor. Trends Endocrin Met 12: 210-217, 2001.
19. Knupnick JG and Benovic JL: The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38: 289-319, 1998.
20. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D and Karaplis AC: Nucleoral localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 115: 4064-4075, 1995.
21. Veronica A, Sepulveda T and Falzon M: Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Regul Peptides 105: 109-120, 2002.
22. Veronica A, Sepulveda T, Shen X and Falzon M: Intracrine PTHrP protects against serum-starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143: 596-606, 2002.
23. Deftos LJ: Prostate carcinoma (Production of bioactive factors). Cancer Supplement (Skeletal Complications of Malignancy) 88: 3002-3008, 2000.
24. Ogata E: Parathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidity. Cancer Supplement (Skeletal Complications of Malignancy) 88: 2909-2911, 2000.
25. Lam MHC, Briggs LJ, Hu W et al: Importin β recognizes parathyroid hormone-related protein (PTHrP) with high affinity and mediates its nuclear import in the absence of importin α. J Biol Chem 274: 7391-7398, 1999.
26. Watson PH, Fraher LJ, Hendy GN, Chung UI, Kisiel M, Natale BW and Hodsman AB: Nuclear localization of the type I PTH/PTHrP receptor in rat tissues. J Bone Miner Res 15: 1033-1044, 2000.
27. Guise TA: Parathyroid hormone-related protein and bone metastases. Cancer Supplement (Skeletal Complications of Malignancy) 80: 1572-1580, 1997.
28. Li X and Drucker DJ: Parathyroid hormone-related peptide is a down-stream target for ras and src activation. J Biol Chem 269: 6263-6266, 1994.
29. Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE and Baron R: Bcl-2 lies down-stream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 136: 205-213, 1997.
30. Dittmer J, Gitlin SD, Reid RL and Brady JN: Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotrophic virus type 1 Tax1: Evidence for the involvement of transcription factor ets 1. J Virol 67: 6087-6095, 1993.
31. Inoue D, Matsumoto T, Ogata E and Ikeda K: 22-oxacalcitriol, a non-calcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus type 1-infected T cells. J Biol Chem 268: 16730-16736, 1993.
32. Takahashi K, Inoue D, Ando K, Matsumoto T, Ikeda K and Fujita T: Parathyroid related-peptide as a locally produced vasorelaxant: Regulation of its m-RNA by hypertension in rats. Bioch Bioph Res Commun 208: 447-455, 1995.
33. Pirola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL and Fagin JA: Angiotensin-II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and posttranscriptional mechanism. J Biol Chem 268: 1987-1994, 1993.
34. Hongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrest JS, Singer FR, Goltzman D, Hendy GN, Pirola C and Clemens TL: Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanied serum-induced proliferation. J Clin Invest 88: 1841-1847, 1991
35. Pirola CJ, Wang HM, Stragacich MI, Kamyar A, Cercek B, Forrester JS, Clemens TL and Fagin JA: Mechanical stimuli induced vascular parathyroid hormone-related protein gene expression in vivo and in vitro. Endocrinology 134: 2230-2236, 1994.
36. Ozeki S, Ohtsuru A, Seto S, Takeshita T, Yano H, Nakayama T, Ito M, Yokota T, Nobuyoshi M, Segre GV, Yamashita S and Yano K: Evidence that implicate the parathyroid hormone-related peptide in vascular stenosis: Increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Atrerioscler Thromb Vasc Biol 16: 565-575, 1996.
37. Nickols GA, Nana AD, Nickols MA, Dipette DJ and Asimakis GK: Hypotension and cardiac stimulation due to parathyroid hormone-related protein, humoral hypercalceamia of malignancy factor. Endocrinol 125: 834-841, 1989.
38. Qian J, Lorenz JN, Maeda S, Sutlif RL, Weber C, Nakayama T, Colbert MC, Paul RJ, Fagin JA and Clemens TL: Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinol 140: 1826-1833, 1999.
39. McDaniel NL, Rembold CM and Murhy RA: Cyclic nucleotide dependent relaxation in vascular smooth muscle. Can J Physiol Pharmacol 72: 1380-1385, 1994.
40. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ and Stewart AF: Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting. Proc Natl Acad Sci USA 94: 13630-13635, 1997.
41. Demiguel F, Fiaschi-Taesch N, Lopez-Talavera JC, Takane KK, Massfelder T, Helwig JJ and Stewart AF: The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinol 142: 4096-4105, 2001.
42. Nakayama T, Ohtsuru A, Enomoto H, Namba H, Ozeki S, Shibata Y, Yokota T, Nobuyoshi M, Ito M, Sekine I and Yamashita S: Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem Biophys Res Commun 200: 1028-1035, 1994.
43. Jono S, Nishizawa Y, Shioi A and Moril H: Parathyroid related peptide as a local regulator of vascular calcification. Arterioscler Thromb Vasc Biol 17: 1135-1142, 1997.
44. Schluter K, Katzer C, Friskopf K, Wenzel S, Taimor G and Piper HM: Expression, release and biological activity of parathyroid hormone related peptide from coronary endothelial cells. Circ Res 86: 946-951, 2000.
45. Degenhart H, Jansen J, Schulz R, Sedding D, Braun Dullaeus R and Schluter KD: Mechanosensitive release of parathyroid hormone-related peptide from coronary endothelial cells. Am J Physiol Heart Circ Physiol 283: H1489-H1496, 2002.
46. Daifotis AG, Weir EC, Dreyer BE and Broadus AE: Stretch-induced parathyroid hormone-related peptide gene expression in the uterus. J Biol Chem 267: 23455-23458, 1992.
47. Eto M, Akishita M, Ishikawa M, Kozaki K, Yoshizumi M, Hashimoto M, Ako J, Sugimoto N, Nagano K, Sudoth N, Toba K and Ouchi Y: Cytokine-induced expression of parathyroid hormone-related peptide in cultured human vascular endothelial cells. Biochem Bioph Res Commun 249: 339-343, 1998.
48. Schorr K, Taimor G, Degenhard H, Weber K and Schluter KD: Parathyroid hormone related-peptide is induced by stimulation of alpha (1A) adrenoreceptor and improves resistance against apoptosis in coronary endothelial cells. Mol Pharmacol 63: 111-118, 2003.
49. Henriksen T, Bucht E, Gautvik KM, Rian E, Jemtland R, Olstad OK, Endersen MJ, Grasser WA and Thiede MA: Parathyroid hormone-related protein is produced by cultured endothelial cells: A possible role in angiogenesis. Bioch Biophys Res Commun 198: 740-747, 1994.
50. Deftos LJ, Burton DW and Brand DW: Parathyroid hormone-like protein is a secretory product of atrial myocytes. J Clin Invest 92: 727-735, 1993.
51. Bui TD, Shallal A, Malik AN, Al-Mahdawi S, Moscoso G, Bailey ME, Burton PB and Moniz C: Parathyroid hormone-related peptide gene expression in human fetal and adult heart. Cardiovasc Res 27: 1204-1208, 1993.
52. Burton DW, Brand DW and Deftos LJ: Parathyroid hormone-related protein in the cardiovascular system. Endocrinol 135: 253-261, 1994.
53. Hara M, Liu YM, Zhen L, Cohen IS, Yu H, Danilo P, Ogino K, Bilezikian JP and Rosen MR: Positive chronotropic action of parathyroid hormone and parathyroid hormone-related peptide are associated with increase in the current, if, and the slope of the pacemaker potential. Circul 96: 3704-3709, 1997.
54. Schluter KD, Weber M and Piper HM: Effects of PTHrP (107-111) and PTHrP (7-34) on adult cardiomyocytes. J Mol Cell Cardiol 29: 3057-3065, 1997.
55. Schluter KD, Katzer C and Piper HM: A N-terminal PTHrP peptide fragment void of a PTH/PTHrP-receptor binding domain activates cardiac ET-A receptor. Br J Pharmac 132: 427-432, 2001.
56. Qian J, Colbert MC, Witte D, Kuan CY, Gruenstein E, Osinka H, Lanske B, Kronenberg HM and Clemens TL: Midgestational lethality in mice lacking the parathyroid hormone (PTH)/PTH-related peptide receptor is associated with abrupt cardiomyocyte death. Endocrinol 144: 1053-1061, 2003.
57. Ogino K, Ogura K, Kinugasa Y, Furuse Y, Uchida K, Shimoyama M, Kinugawa T, Osaki S, Kato M, Tomikura Y, Igawa O, Hisatome I, Bilezikian J and Shigemasa S: Parathyroid hormone related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrin Metab 87: 4722-4727, 2002.